– Go grandmaster demonstrates the future of human and AI collaboration at the site of the historic AlphaGo match as Enhans unveils its multi agent AI OS

SEOUL, South Korea, March 9, 2026 /PRNewswire/ — Enhans, an enterprise Agentic AI company led by CEO Seung-hyun Lee, announced the beginning of a new era of human and AI collaboration during a live event held today at the Four Seasons Hotel Seoul alongside Go grandmaster Lee Sedol.

The event took place at the same venue where Lee Sedol faced DeepMind’s AlphaGo in 2016. Marking the tenth anniversary of that historic match, Enhans presented a new narrative for artificial intelligence under the message “The Age of Agentic AI.” While the original match symbolized competition between humans and machines, the new demonstration showed how AI can evolve into a collaborative partner capable of understanding human intent and executing complex work.

The highlight of the event was a live demonstration in which Lee Sedol collaborated directly with Enhans’ AI agents on stage. Using only voice commands, Lee worked with the Enhans AI OS to reconstruct a Go model in real time and then played a match against the newly generated system.

Enhans also demonstrated how its multi agent architecture enables AI to execute complex workflows autonomously. With a single voice command, the AI OS distributed tasks across specialized agents responsible for real time web research, planning, coding, and deployment.

Rather than relying on a single model, the Enhans AI OS operates through multiple specialized agents that collaborate to solve problems. When a user issues a request, the system interprets the intent and assigns tasks to agents responsible for ontology reasoning, planning, and computer execution.

For example, a request such as researching competitors’ products, prices, and specifications and generating a comparison report can trigger coordinated activity across the Computer Using Agent (CUA), ontology agents, and planning agents. This process demonstrates how business workflows can be executed autonomously without manual coding or complex system manipulation.

The AI OS presented during the event represents Enhans’ full vision of a unified multi agent system designed for collaborative execution. While the architecture continues to evolve, many of its core capabilities including web search, commerce automation, planning, design, and coding are already operational and integrated into the company’s Commerce OS platform.

The event was officially sponsored by Anthropic, NVIDIA, and Microsoft and was broadcast globally through a live YouTube stream.

Lee Sedol shared his perspective following the demonstration.

“Enhans’ Agentic AI felt like a powerful collaborator that turns imagination into reality,” Lee said. “AI should no longer be defined as an opponent but as a tool that allows humans to unlock greater creativity.”

Seung-hyun Lee, CEO of Enhans, said the event reflects a fundamental shift in the role of artificial intelligence.

“If the AlphaGo match symbolized competition between humans and AI, today marks the beginning of collaboration,” Lee said. “Our goal is to standardize the core technologies behind this shift including Ontology, Agentic AI, and LAM and open an era in which enterprises worldwide can work alongside AI agents.”

Founded in 2021, Enhans is an AI OS company focused on automating workflows across vertical industries. The company’s platform is built on two core technologies. Ontology enables AI agents to understand industry and business context. Computer Using Agent (CUA) is an execution engine designed to operate in real computer environments and complete tasks from start to finish. By combining understanding and execution in an agent centric AI OS, Enhans aims to introduce a new paradigm in which AI can autonomously decide and act.

Enhans has also gained international recognition for its technology. In May 2025 the company was selected as the only Korean participant in Palantir’s Startup Fellowship. Its web AI agent model ACT 1 ranked among the top systems on the global Online Mind2Web benchmark leaderboard alongside models from OpenAI, Google, and Anthropic. The model achieved first place in DOM control performance and first place in the vertical commerce category. The system has since evolved into its next generation version ACT 2.

For more information, visit https://www.enhans.ai/

News Summary:

• At Legalweek 2026, Relativity is unveiling a refreshed brand identity that more clearly represents the role it plays across modern legal data workflows.
• Relativity has long supported a broad range of legal data needs, with non-litigation matters now accounting for more than 55 percent of the data coming into RelativityOne.
• Relativity aiR for Data Breach Response is now generally available, expanding the aiR suite with workflow-driven automation purpose-built for high-stakes breach response.

CHICAGO, March 9, 2026 /PRNewswire/ — Relativity, a legal data intelligence company, today unveiled a refreshed brand identity at Legalweek 2026. As explosive data growth, expanding use cases, and advances in AI reshape the legal industry, Relativity’s brand is evolving to more accurately reflect the role it plays in helping customers and partners turn complex data into insights and action.

“For 25 years, Relativity has positively disrupted itself to stay ahead of where legal work is going. That commitment — to being on the front foot and never on our heels — is what made us a trailblazer in e-discovery, and what we believe positions us to lead in legal data intelligence,” said Phil Saunders, CEO of Relativity. “We were born in litigation, and e-discovery remains core to our DNA as our community now actively leverages RelativityOne — the AI platform for legal data intelligence — to support a much broader range of legal workflows. This brand refresh expands our story; it doesn’t alter our foundation, and it’s rooted in our customers’ realities.”

More than a decade ago, Relativity embedded AI into its platform and moved decisively to the cloud, and today it is bringing that same foresight to support the mounting demands of modern legal work. Legal Data Intelligence (LDI) spans litigation, investigations, regulatory inquiries, data breach responses, privacy matters, contract reviews, public records requests, data subject access requests (DSARs) and more.

With non-litigation matters now accounting for more than 55 percent of the data coming into RelativityOne, this category more accurately reflects how Relativity’s community is using the platform beyond traditional e-discovery. The refreshed language and visual identity are designed to capture the meaningful expansion in usage, the types of problems customers and partners are solving, and the growth of the community. By aligning messaging with customers’ and partners’ real-world experiences, Relativity strengthens its role in supporting modern legal workflows.

View the brand refresh and explore the full story behind it in this blog.

Relativity aiR for Data Breach Response Now Generally Available

As part of its expanded LDI capabilities, Relativity announced the general availability of Relativity aiR for Data Breach Response. Workflow-driven automation helps organizations respond to breach incidents faster and more accurately without sacrificing defensibility. In a Total Economic Impact study conducted by Forrester Consulting, organizations using aiR for Data Breach Response reported up to 60 percent savings in reviewer time costs. The solution’s enhanced capabilities reduce manual effort in high-stakes response workflows while supporting transparency, human oversight and compliance with regulatory and legal requirements.

Using aiR for Data Breach Response helps teams identify personally identifiable information (PII) and protected health information (PHI) across multiple file types, link sensitive data to potentially impacted individuals, and deduplicate results to create consolidated, reviewable profiles. Purpose-built for breach response, the solution flags anomalies and potential risks for expert validation, provides clear rationale and traceability for outputs, and streamlines the creation of affected-individual lists and notification-ready reporting as response timelines continue to tighten — all within the secure RelativityOne offering.

Relativity aiR for Case Strategy Accelerates Case Intelligence at Scale

Relativity aiR for Case Strategy, which became generally available in January 2026, is seeing strong early adoption as legal teams look to accelerate case intelligence and narrative development. Designed to make it faster and simpler to build case strategy, the solution enables users to extract key facts automatically, visualize chronologies, accelerate deposition preparation, and generate summaries across documents, witnesses, and transcripts.

Customers have run more than 1 million documents through aiR for Case Strategy. To date, the solution has extracted more than 800,000 facts. By transforming unstructured documents into structured, reviewable facts and timelines, aiR for Case Strategy helps legal teams surface critical insights earlier, align on narrative faster, and move forward with greater speed and confidence.

Relativity aiR Transforms Document Review

Using Relativity aiR for Review and Relativity aiR for Privilege, legal teams have already made more than 240 million defensible review predictions across thousands of matters — and with adoption increasing rapidly, this momentum marks the beginning of a broader expansion of aiR’s impact in 2026. With aiR for Review, customers report reducing review time by up to 85 percent and surfacing up to 30 percent more relevant documents compared to manual review and 10-20 percent more than other traditional technology-assisted review (TAR) approaches, delivering faster, more accurate results within a single workflow. As aiR solutions for review, such as aiR for Review and aiR for Privilege, become integral to LDI work, the solutions will be included in the standard pricing and packaging for RelativityOne in April, as announced at Relativity Fest 2025.

In a recent multi-party matter, global law firm Foley & Lardner LLP leveraged aiR for Review to complete a half-million document review, completing the entire workflow — culling, prompt iteration, validation and full-scale analysis — in under a week. Once the initial review was complete, Foley compared issue-coded signals across outgoing and incoming productions, using aiR for Review’s reasoning to identify matches, contrasts and gaps in the narrative emerging from each party’s documents.

“Being able to quickly compare issue patterns across incoming and outgoing productions fundamentally changed how we viewed the facts and determined areas of focus,” said Nick Cole, Director of Litigation Support at Foley & Lardner. “Without aiR for Review, that level of analysis simply wouldn’t have been possible.”

Relativity at Legalweek 2026

Attendees of Legalweek 2026 are encouraged to visit Relativity’s community hub, RelHQ at Convene 30 Hudson Yards, for free new branded merchandise, product-focused learning labs, and opportunities to connect. Relativity will also be stationed on the conference floor at the North Javits Center, booth #501, offering hands-on demonstrations of Relativity aiR solutions.

On Wednesday, March 11, Relativity thought leaders will participate in sessions exploring the role of generative AI in legal work, including a mock argument on its use for document review and production, a discussion about the legal data challenges faced by celebrities, and an interactive prompting challenge offering practical techniques for producing accurate AI-generated content. View the Legalweek 2026 agenda for more details.

Relativity recently unveiled its fifth annual list of AI Visionaries, spotlighting the changemakers transforming how AI is understood, applied and integrated across the legal ecosystem. During Legalweek 2026, the AI Visionaries will gather at a recognition dinner dedicated to celebrating their collective impact and contributions to the industry.

About Relativity 
Relativity is a leading legal data intelligence company that builds technology to help users organize data, discover the truth, and act on it. Its extensible, AI-powered cloud platform, RelativityOne, transforms complex data into actionable insights at massive scale for litigation, investigations, regulatory inquiries, data breach responses, and other legal use cases. The world’s largest law firms and corporations, government agencies, and a robust network of channel partners rely on Relativity’s legal AI software to securely surface and manage the most relevant and impactful information in their matters. The company also expands access to technology by providing its platform at no cost to academic institutions through its Relativity Academic program and to organizations supporting pro bono legal work through its Justice for Change initiative. 

DUBAI, UAE, March 9, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, today announced the appointment of Derek Dai as Country Manager for the Middle East and North Africa (MENA), reinforcing the company’s long-term commitment to the United Arab Emirates as a strategic hub for digital asset innovation.

In this role, Derek will lead Bybit’s regional strategy across MENA, overseeing market expansion, regulatory collaboration, institutional partnerships, and localized product development as the company continues to strengthen its regulated footprint following its recent Securities and Commodities Authority (SCA) license.

“The UAE gave Bybit a home. You do not abandon your home when the storm comes — you stand in the doorway,” said Helen Liu, co-CEO of Bybit. “Some companies are reassessing their Gulf exposure right now. We are doing the opposite. We are deepening our presence, our investment, and our commitment to this region.”

Bybit’s appointment of Derek comes at a pivotal moment for the region — a decision made not despite the current geopolitical uncertainty, but because of it.

A Strategic Moment for the Middle East

“The Middle East is emerging as one of the most important regions shaping the future of digital finance, with the UAE leading the way in building a progressive and well-regulated ecosystem,” said Derek Dai, Country Manager for MENA at Bybit.

“Our priority is to deepen collaboration with financial centers such as DIFC and DMCC, while strengthening the infrastructure that connects digital assets with everyday financial services and advancing the development of tokenized real-world assets that bridge traditional finance and the digital asset economy.”

“In the coming months, we will focus on expanding AED fiat access, building partnerships with banks and payment providers, and enhancing our Islamic finance offerings through the development of more Shariah-compliant products,” Derek added. “By working closely with regulators, institutions, and builders, we aim to support the next phase of responsible digital asset adoption across the Middle East, while expanding our presence across the GCC, with Bahrain representing one of the next key milestones for Bybit in the region.”

Building Long-Term Roots in the UAE

Bybit views the UAE not only as a market, but as a strategic bridge between traditional financial systems and the emerging digital asset economy.

As part of its commitment to the local community, the company partnered with the Emirates Red Crescent during Ramadan to support the Iftar Tent initiative, providing meals throughout the holy month and organizing employee volunteer activities to assist families and individuals in need.

Amid the recent geopolitical tensions in the Middle East, Bybit has also taken proactive steps to ensure the safety and well-being of its UAE-based employees while maintaining stable services for its global users. The company activated comprehensive Business Continuity Protocols (BCP) across its Dubai and Abu Dhabi operations, introducing daily management check-ins, real-time employee safety confirmations, and relocation or travel assistance for staff in sensitive areas.

“Bybit’s commitment to the UAE was made for the long term — through growth and through adversity,” said Helen. “We continue to invest in local talent, regulatory compliance, and community partnerships. The UAE’s vision to become the world’s leading digital asset hub is not diminished by this crisis. If anything, the resilience this nation is showing only reinforces why we chose to build here.”

“Our users in the UAE, Saudi Arabia, Qatar, and across the Gulf need to know one thing: Bybit is open, Bybit is liquid, and Bybit is staffed around the clock,” Derek added. “Your funds are safe. Your access is uninterrupted. We are not going offline, and we are not leaving.”

A Message to the UAE Community

“To our entire UAE family — our users, our partners, our colleagues, and every family across the Emirates — Bybit stands with you,” said Helen Liu. “We wish safety, strength, and peace to everyone affected by this conflict. The UAE has shown the world what courage and resilience look like, and we are honored to stand alongside this community. We are here today, we will be here tomorrow, and we will be here long after this crisis passes.”

#Bybit / #TheCryptoArk

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 80 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.

For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: media@bybit.com
For updates, please follow: Bybit’s Communities and Social Media

• Over 40 AI models lightweighted and optimized across more than 100 devices; technologies adopted by global leaders including Samsung and NVIDIA
• Live demonstrations of LLM and computer vision models running in real time on Qualcomm and Arm hardware, alongside a Device Farm exhibit showcasing edge AI optimization capabilities
• Real-world applications of NVA (Nota Vision Agent) in safety, security, and smart city operations; VLA research recognized at ICLR and AAAI highlights Nota’s technological leadership

SEOUL, South Korea, March 9, 2026 /PRNewswire/ — Nota AI, an AI optimization technology company, announced that it will participate in Embedded World 2026, taking place March 10-12 in Nuremberg, Germany. At the event, the company will present the full lifecycle of on-device AI-from model optimization to deployment in real-world industrial environments.

Embedded World is one of the world’s largest exhibitions and conferences dedicated to embedded systems, bringing together approximately 1,000 exhibitors and more than 30,000 industry professionals. Global semiconductor, software, and mobility companies including AMD, Intel, and Qualcomm participate in the event. Through its exhibition, Nota AI will showcase how AI models are optimized through NetsPresso® and deployed across a wide range of global hardware platforms before being implemented in real industrial environments.

At the event, Nota AI will demonstrate how semiconductor companies can rapidly optimize high-performance AI models for their chips using its AI model optimization platform, NetsPresso®. The company has accumulated extensive expertise in lightweighting and optimizing AI models—from small language models (SLMs) to large language models (LLMs) and vision-language models (VLMs). To date, Nota AI has successfully compressed more than 40 AI models while maintaining performance and has deployed its optimization technologies across over 100 hardware devices.

Nota AI’s AI lightweighting and optimization technologies have already been recognized in the global market. The company recently supplied AI optimization technology for Samsung Electronics’ Exynos 2600, where the technology serves as a core component enabling mobile on-device AI capabilities. Nota AI has also maintained ongoing technology collaborations with global semiconductor companies including Qualcomm and Arm. At Embedded World, the company will present live demonstrations showing both computer vision models and large language models running in real time on these hardware platforms, highlighting AI performance in edge environments.

Nota AI will also showcase a Device Farm, featuring a collection of hardware platforms optimized by the company over the past decade. Visitors will be able to explore a range of chipsets from major global semiconductor companies running AI models optimized with Nota AI’s technology, demonstrating the company’s experience in optimizing more than 100 hardware platforms over the past ten years.

In addition, Nota AI will introduce real-world solutions that combine AI models with hardware optimization in on-device environments. Through its video analytics solution NVA (Nota Vision Agent), Nota AI has delivered technologies across industries such as safety monitoring, security, and smart city operations in collaboration with global partners including NVIDIA. At the booth, the company will demonstrate real deployment cases including selective video monitoring, intelligent transportation systems (ITS), and industrial safety monitoring.

Nota AI will also present its latest research achievements recently accepted at ICLR 2026 and the AAAI 2026 Foundation Model Workshop. Both studies focus on improving the efficiency and reliability of vision-language models (VLMs), highlighting Nota AI’s technological capabilities across the broader physical AI landscape-from vision-language models to vision-language-action (VLA) systems.

During the exhibition, Tae-Ho Kim, CTO & Co-Founder of Nota AI, will host mini sessions at the booth to present the company’s AI lightweighting and optimization strategies and share real-world cases of applying Nota AI technologies to global semiconductor platforms. The sessions will provide insights into Nota AI’s approach to efficiently running AI models on edge devices and the company’s technological differentiation.

“Nota AI has continuously advanced lightweighting and optimization technologies that enable AI models to run efficiently across more than 100 types of hardware without being limited to a single device architecture,” said Myungsu Chae, CEO of Nota AI. “Through Embedded World, we look forward to sharing how our technologies operate across diverse global hardware environments and how they are being applied in real industrial settings.”

Nota AI will offer complimentary Embedded World visitor passes to attendees who pre-register through the company’s official website and visit the Nota booth (Hall 5, Booth 5-422).

• Robots deployed across assembly, inspection, and riveting processes; expanded order secured following zero-defect achievement
• Companies to extend collaboration to additional production lines and co-develop customized automation solutions

SEONGNAM, South Korea, March 9, 2026 /PRNewswire/ — Doosan Robotics announced it will supply more than 100 manufacturing robot solutions to Kwangjin Group, a global automotive components manufacturer, under a strategic partnership.

Doosan Robotics announced on March 9 that it has signed a Memorandum of Understanding (MOU) with Kwangjin Group at Bundang Doosan Tower in Seongnam, Korea. Through this agreement, the two companies will collaborate on manufacturing process automation and strengthen quality competitiveness by deploying Doosan robot solutions.

Kwangjin Group specializes in automotive door system components and operates production facilities in key global markets, including the United States, Mexico, India, and Vietnam. Its major customers include leading global automakers such as General Motors, Ford Motor Company, Navistar, Volkswagen, Hyundai Motor, and Honda. Kwangjin Group has already integrated Doosan Robotics’ solutions into the riveting, assembly, and inspection processes of its window regulator and door module production lines.

Under the agreement, Doosan Robotics will sequentially supply more than 100 manufacturing robot solutions to Kwangjin Group’s domestic and overseas plants through 2027.

The expanded supply agreement represents formal validation of Doosan Robotics’ technological capabilities and reliability within the global automotive supply chain. Notably, following the deployment of Doosan’s manufacturing robot solutions, product defect rates were reduced to zero — an achievement that played a decisive role in securing the large-scale follow-up order.

Doosan Robotics’ manufacturing solutions can be implemented without modifications to existing factory layouts. They offer high levels of safety and precision, enabling effective human-robot collaboration. By minimizing quality variations caused by differences in operator skill levels, the solutions deliver consistent quality and meaningful defect reduction. In addition, they shorten production cycle times, enhance overall productivity, and support stable plant operations.

Building on this partnership, the two companies plan to expand their collaboration beyond large-scale deployment by jointly developing customized robot solutions tailored to additional component manufacturing processes. A joint task force will also be established to develop phased implementation strategies and optimize production environments for robot integration.

Inwon Park, CEO of Doosan Robotics, stated, “This agreement reflects the strong trust placed in our robot solutions, particularly following the achievement of a zero-defect rate, which directly led to this expanded partnership. We will ensure the successful deployment of our solutions across Kwangjin Group’s production facilities and further strengthen our position in the global automation market through close collaboration.”

Following its Best of Innovation award in the AI category at CES 2026 for its AI Sanding solution, Doosan Robotics is broadening its portfolio of safe, high-productivity AI robot solutions while accelerating R&D to lead the next wave of manufacturing innovation.

ABOUT DOOSAN ROBOTICS

Doosan Robotics is a global leader in collaborative robot solutions, delivering cutting-edge AI robotics to 45 countries worldwide. Renowned for world-class safety and performance, Doosan Robotics serves blue-chip customers across various industries, including automotive, electronics, semiconductor, logistics, and energy. More information about Doosan Robotics is available at https://www.doosanrobotics.com/en/.

CHENGDU, China, March 9, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (“Kelun-Biotech” or the “Company”, 6990.HK) and Harbour BioMed (HKEX: 02142) today announced that the National Medical Products Administration (NMPA) of China has approved the Investigational New Drug (IND) application for SKB575/HBM7575, a long-acting bispecific antibody targeting thymic stromal lymphopoietin (TSLP) and an undisclosed target co-developed by the two parties, for the treatment of atopic dermatitis.

Atopic dermatitis is a chronic, inflammatory skin disease characterized by persistent itching, redness, and irritation. It affects around 20% of children and up to 10% of adults worldwide^[1]. Though not infectious, atopic dermatitis has a profound impact on patients’ quality of life due to its cyclical nature of flare-ups and remissions. Current treatments, including topical corticosteroids, biologics, and Janus kinase (JAK) inhibitors, provide symptomatic relief for many patients, but often fail to deliver sustained disease control, especially in moderate-to-severe cases. Therefore, there is an urgent need for safer, more effective, and durable treatments that address underlying disease mechanisms and improve long-term outcomes.

Dr. Michael Ge, CEO of Kelun-Biotech, stated: “We are delighted to see the approval of SKB575/HBM7575 for clinical trials in atopic dermatitis. This marks an important milestone in our strategic expansion in the field of autoimmune diseases and holds promise for offering a novel therapeutic option to patients with atopic dermatitis. As a bispecific antibody with a differentiated innovative mechanism and a long-acting profile, SKB575/HBM7575 holds the potential to deliver durable and stable disease control while improving patient treatment experience through reduced dosing frequency.”

Dr. Jingsong Wang, Founder, Chairman, and CEO of Harbour BioMed, commented: “The NMPA’s IND approval for HBM7575/SKB575 marks an important step forward in addressing the significant unmet needs in autoimmune diseases such as atopic dermatitis. By targeting TSLP, a key upstream driver of type 2 inflammation, and an undisclosed target, HBM7575/SKB575 has the potential to be a best-in-class bispecific antibody for this disease. We look forward to advancing this investigational therapy through clinical development and believe its long-acting profile may offer a differentiated treatment option for patients worldwide.”

About SKB575/HBM7575

SKB575/HBM7575 is a long-acting bispecific antibody targeting thymic stromal lymphopoietin (TSLP) and an undisclosed antigen, with a dual mechanism of action. On one hand, by blocking the interaction between TSLP and its receptor, it inhibits TSLP-mediated signaling pathways and the activation of Th2 immune cells. On the other hand, binding to and blocking the undisclosed target generates a synergistic effect, overcoming resistance issues associated with TSLP single-target antibodies. SKB575/HBM7575 has been engineered to possess an extended half-life and favorable developability, enabling subcutaneous administration. Based on preclinical half-life data, the anticipated human half-life is expected to support dosing intervals of more than three months, positioning it as a potential best-in-class therapy.

According to the collaboration agreement between the Company and Harbour BioMed, SKB575/HBM7575 is led by Kelun-Biotech in its design, global development and commercialization, with Harbour BioMed participating in the investment and development of this asset and sharing the benefits as agreed.

About Kelun-Biotech

Kelun-Biotech (6990.HK) is a holding subsidiary of Kelun Pharmaceutical, which focuses on the R&D, manufacturing, commercialization and global collaboration of innovative biological drugs and small molecule drugs. Kelun-Biotech focuses on major disease areas such as solid tumors, autoimmune, inflammatory, and metabolic diseases, and in establishing a globalized drug development and industrialization platform to address the unmet medical needs in China and the rest of world. Kelun-Biotech is committed to becoming a leading global enterprise in the field of innovative drugs. At present, Kelun-Biotech has more than 30 ongoing key innovative drug projects, of which 4 projects with 8 indications have been approved for marketing, 1 project is in the NDA stage and more than 10 projects are in the clinical stage. Kelun-Biotech has established one of the world’s leading proprietary ADC and novel DC platforms, OptiDC™, and has 2 ADC projects with 5 indications approved for marketing, and multiple ADC and novel DC assets in clinical or preclinical research stage. For more information, please visit https://en.kelun-biotech.com/.

About Harbour BioMed

Harbour BioMed (HKEX: 02142) is a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology. The company is building a robust and differentiated pipeline through internal R&D capabilities, strategic global collaborations in co-discovery and co-development, and selective acquisitions.

Harbour BioMed’s proprietary antibody technology platform, Harbour Mice^®, generates fully human monoclonal antibodies in both the conventional two heavy and two light chain (H2L2) format and the heavy chain-only (HCAb) format. Building upon HCAb antibodies, the HCAb-based immune cell engagers (HBICE^®) bispecific antibody technology enables tumor-killing effects that traditional combination therapies cannot achieve. Additionally, the HCAb-based bispecific immune cell antagonist (HBICA^TM) technology empowers the development of innovative biologics for immunological and inflammatory diseases. By integrating Harbour Mice^®, HBICE^®, and HBICA^TM with a single B-cell cloning platform, Harbour BioMed has built a highly efficient and distinctive antibody discovery engine for developing next-generation therapeutic antibodies. For more information, please visit www.harbourbiomed.com.